glp 1 medication shortage An Ongoing Crisis: Semaglutide Raises Dual Concerns for Obesity and Diabetes Treatment GLP-1 No Longer on FDA's

Supporting beneficial bacteria may help promote digestive balance and metabolic wellness

telehealth and medically integrated programs

Learn how Wegovy and Zepbound interact with alcohol, potential side effects, tolerance changes, and expert tips for drinking safely while on GLP-1 medications.

The patented active ingredient, Amarasate, is encased in a delayed-release capsule for targeted release, triggering the bitter taste receptors (TAS2R) of enteroendocrine cells predominantly found along the duodenum

Patients typically experience a 15-20% reduction in weight.

It features top-rated ingredients that have been clinically tested to target appetite control, mood elevation, thermogenesis, energy, weight loss, stamina, and more.*